The standard schedule increases the dose every four weeks, from 0.25 mg up to the 2.4 mg maintenance dose over about 16 weeks
We provide continuous support for nutrition, mindset, and exercise to keep you accountable and motivated
In contrast, research peptides are labeled "for research use only" and not intended for human consumption
With medications like semaglutide, patients may lose 1015% of their body weight over 612 months
Commonly combined peptides include CJC-1295/Ipamorelin (for muscle preservation and recovery support), Semaglutide or Tirzepatide (for appetite control via different mechanisms), and Tesamorelin (for dual-pathway fat reduction)
A structured dose progression, typically increasing every 24 weeks, maximizes safety and tolerability while achieving consistent weight loss